RX Extraction Ltd specialises in the conversion of cannabis plant material into defined cannabinoid active pharmaceutical ingredients (APIs).
Using advanced supercritical CO₂ extraction, controlled purification and crystallisation processes, we transform complex botanical inputs into consistent, high-quality cannabinoid active substances suitable for medicinal development, research, and pharmaceutical supply chains.
Our work focuses on the technical challenges of cannabinoid manufacture: selectivity, purity, reproducibility, and scalability — bridging the gap between raw plant material and pharmaceutical-grade outputs. All activities are conducted within an MHRA-inspected GMP framework, ensuring that technical performance is matched by regulatory confidence.
RX Extraction was established to support a UK-based medicinal cannabis supply chain, reducing reliance on imported intermediates while maintaining pharmaceutical standards.
